Population-Level Outcomes of Pediatric Acute Promyelocytic Leukemia in the United States
- 1 August 2020
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 223, 114-119.e5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APLBlood, 2018
- Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631Journal of Clinical Oncology, 2017
- Acute myeloid leukemia in children and adolescents: identification of new molecular targets brings promise of new therapiesHematology-American Society Hematology Education Program, 2015
- Treatment of paediatric APL: How does the therapeutic approach differ from adults?Best Practice & Research Clinical Haematology, 2014
- How I treat children and adolescents with acute promyelocytic leukaemiaBritish Journal of Haematology, 2013
- Acute promyelocytic leukemia: A population‐based study on incidence and survival in the United States, 1975‐2008Cancer, 2012
- Outcome of Acute Promyelocytic Leukemia (APL) in Children and Adolescents: An Analysis in Two Consecutive Trials of the European APL GroupJournal of Clinical Oncology, 2012
- Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acidBlood, 2011
- Treatment of children with acute promyelocytic leukemia: Results of the first North American intergroup trial INT0129Pediatric Blood & Cancer, 2009
- Hypothesis testing when a nuisance parameter is present only under the alternative: Linear model caseBiometrika, 2002